Contributions of the Biofilm Matrix to Candida Pathogenesis

Area of Science:

• Medical Mycology
• Infectious Diseases
• Biomaterials Science

Background:

• Invasive fungal infections, primarily caused by *Candida* species, are a significant cause of mortality in healthcare settings.
• These infections are frequently associated with indwelling medical devices, particularly vascular catheters.
• *Candida* forms resilient biofilms on these devices, characterized by an extracellular matrix that enhances adhesion and protection.

Purpose of the Study:

• To review the medical significance of device-associated *Candida* biofilms.
• To elucidate the process of *Candida*-biofilm-matrix production.
• To update the understanding of the extracellular matrix's role in fungal pathogenicity, antifungal drug tolerance, and immune evasion.

Main Methods:

• Literature review focusing on *Candida* biofilms and their extracellular matrix.
• Analysis of current research on biofilm formation and pathogenicity mechanisms.
• Synthesis of information regarding the matrix's contribution to antifungal resistance and immune evasion.

Main Results:

• Device-associated *Candida* biofilms represent a critical challenge in healthcare-associated infections.
• The extracellular matrix is pivotal in promoting fungal adhesion to medical devices.
• The matrix plays a key role in conferring antifungal drug tolerance and facilitating immune evasion by *Candida*.

Conclusions:

• Understanding *Candida* biofilm matrix production is crucial for developing effective therapeutic strategies.
• Targeting the biofilm matrix may offer a novel approach to combatting device-associated candidiasis.
• Further research into matrix composition and function is warranted to improve patient outcomes.